Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12643021 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL19224794 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL16220760 | 1.00 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL16388910 | 0.94 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL19224793 | 0.94 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL16435349 | 0.94 | ALDH1A1 (0.39) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL23998675 | 0.91 | ALDH1A1 (0.41) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL24088233 | 0.89 | MYC (0.35) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL19224778 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KDM4EHPGDTDP1TSHR | |
| SCHEMBL16220758 | 0.88 | ALDH1A1 (0.35) | ALDH1A1KDM4EHPGDTDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| EP-3492480-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-10-20 | — | — | EP | disclosed |
| EP-3858842-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3489249-B1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2021-06-09 | — | — | EP | disclosed |
| US-10975113-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
| EP-3205658-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-03-24 | — | — | EP | disclosed |
| US-20200251667-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | UDC IRELAND LTD (IE) | 2020-08-06 | — | — | US | disclosed |
| EP-3608329-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | UDC Ireland Limited (IE) | 2020-02-12 | — | — | EP | disclosed |
| EP-3266789-B1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | UDC IRELAND LTD (IE) | 2019-09-25 | — | — | EP | disclosed |
| EP-3492480-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2019-06-05 | — | — | EP | disclosed |
| US-9487548-B2 | Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2016-11-08 | — | — | US | disclosed |
| US-9487548-B2 | Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2016-11-08 | — | — | US | disclosed |
| US-20160172606-A1 | LUMINESCENT DIAZA-MONOAZA-AND BENZIMIDAZOLE METAL CARBENE COMPLEXES FOR USE IN ELECTRONIC DEVICES SUCH AS OLEDS | BASF SE (DE) | 2016-06-16 | — | — | US | disclosed |
| US-20160172606-A1 | LUMINESCENT DIAZA-MONOAZA-AND BENZIMIDAZOLE METAL CARBENE COMPLEXES FOR USE IN ELECTRONIC DEVICES SUCH AS OLEDS | BASF SE (DE) | 2016-06-16 | — | — | US | disclosed |
| WO-2015014944-A1 | LUMINESCENT DIAZA- MONOAZA- AND BENZIMIDAZOLE METAL CARBENE COMPLEXES FOR USE IN ELECTRONIC DEVICES SUCH AS OLEDS | BASF SE (DE) | 2015-02-05 | — | — | WO | disclosed |
| WO-2015000955-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | BASF SE (DE) | 2015-01-08 | — | — | WO | disclosed |
| EP-2513125-B1 | METAL COMPLEXES WITH DIAZABENZIMIDAZOLECARBENE LIGANDS AND THEIR USE IN OLEDS | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172606-A1 | LUMINESCENT DIAZA-MONOAZA-AND BENZIMIDAZOLE METAL CARBENE COMPLEXES FOR USE IN ELECTRONIC DEVICES SUCH AS OLEDS | OCIAD1, OCIAD2, OXA1L | ALDH1A1 857/4885KDM4E 2664/4885HPGD 1475/4885 |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2444/4885KDM4E 4587/4885HPGD 1361/4885 |
| US-20200251667-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | DDT, OCIAD1, OCIAD2 | ALDH1A1 563/4885KDM4E 2365/4885HPGD 761/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885KDM4E 4573/4885HPGD 1378/4885 |
| US-10975113-B2 | Organic electroluminescent materials and devices | OSBPL3, OCIAD1, OSBP | ALDH1A1 265/4885KDM4E 4617/4885HPGD 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.